OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HFARM51

H-Farm SpA

Investment Management & Fund OperatorsVerified

H-Farm SpA has a fully diluted share count of 200,156,925 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for H-Farm SpA, as no valuation snapshot data has been computed. This absence prevents a direct comparison to industry_config preferred metrics or cohort medians for the Investment Management & Fund Operators industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the risk of overreliance on specific markets or product lines. H-Farm SpA reported last actual revenue of 63,312,000 EUR, but no growth trajectory or outlook data is available for the current or next fiscal year. The absence of forward-looking guidance limits the ability to assess revenue momentum or strategic direction. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the lack of disclosed capital structure details and valuation metrics limits the ability to evaluate financial health comprehensively. Recent events, including filings or transcripts, are not available in the provided data. This absence limits the ability to assess management commentary, strategic shifts, or regulatory developments that could impact the company's performance.

30-day price · HFARM-0.00 (-1.3%)
Low$0.15High$0.16Close$0.16As of17 May, 00:00 UTC
Profile
CompanyH-Farm SpA
TickerHFARM.MI
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

H-Farm SpA has a fully diluted share count of 200,156,925 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for H-Farm SpA, as no valuation snapshot data has been computed. This absence prevents a direct comparison to industry_config preferred metrics or cohort medians for the Investment Management & Fund Operators industry. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the risk of overreliance on specific markets or product lines. H-Farm SpA reported last actual revenue of 63,312,000 EUR, but no growth trajectory or outlook data is available for the current or next fiscal year. The absence of forward-looking guidance limits the ability to assess revenue momentum or strategic direction. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the lack of disclosed capital structure details and valuation metrics limits the ability to evaluate financial health comprehensively. Recent events, including filings or transcripts, are not available in the provided data. This absence limits the ability to assess management commentary, strategic shifts, or regulatory developments that could impact the company's performance.
Key takeaways
  • H-Farm SpA has no dilution risk from stock options or convertible securities, as basic and diluted shares are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet inputs and no going-concern language in source documents.
  • No profitability or return metrics are available, preventing a comparison to industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed, limiting risk assessment.
  • No growth trajectory or forward-looking guidance is available for the current or next fiscal year.
  • Recent events or management commentary are not disclosed, limiting insight into strategic direction.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$59.1M-$10.8M-$5.6M-$5.7M
FY-3$41.3M-$11.0M$17.7M
FY-2$32.1M-$11.0M-$8.9M-$8.5M
FY-1$35.5M-$7.6M-$7.9M-$10.9M
FY0$36.8M-$8.3M$34.4M$32.0M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$62.9M$7.2M$18.9k
FY-3$80.1M$24.6M$7.1k
FY-2$50.8M$7.8M$18.6k
FY-1$51.9M$7.7M$6.6k
FY0$60.2M$41.9M$5.2k
PeriodOCFCapExFCFSBC
FY-4$403.0k-$5.5M-$5.7M
FY-3$872.0k-$2.1M
FY-2$12.8M-$3.3M-$8.5M
FY-1-$2.0M-$6.5M-$10.9M
FY0-$5.4M-$5.9M$32.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricHFARMActivity
Op margin25.7% medp25 3.6% · p75 52.2%
Net margin21.2% medp25 4.2% · p75 45.9%
Gross margin81.4% medp25 46.5% · p75 95.8%
CapEx / revenue-1.7% medp25 -4.8% · p75 -0.4%
Debt / equity14.8% medp25 0.1% · p75 134.4%
Observations
IR observations
Last actual revenue63,312,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 05:41 UTC#ba7adc44
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 02:59 UTCJob: 215cdb2a